Benicar, prescribed to treat hypertension and high blood pressure, keeps blood vessels from narrowing and improving blood flow. Unfortunately, for some consumers, the side-effects far outweigh the benefits. While first released on the market in 2002, it wasn’t until June 2013 that the FDA issued a warning that Benicar can cause sprue-like enteropathy.
Sprue-like enteropathy is a disorder which can present itself with side effects much like that of celiac disease. Symptoms such as chronic diarrhea, substantial weight loss, vomiting, dehydration, villous atrophy, and even colon perforation – all serious side-effects, all of which typically stop once the medication is discontinued. Which is pretty strong evidence of a connection, right?
For years, users had been suffering from these complications, without realizing that they could be caused by the medication. Often the Benicar problems were misdiagnosed as Celiac disease, but Celiac disease suffers can largely control their symptoms by eliminating gluten from their diet – something that does not improve with Benicar users. While the side-effects typically stop once users cease taking the medication, if taken long enough, a user can be left with long-term intestinal damage, damage such as villous atrophy.
Villous atrophy does not sound good. And it’s not. This occurs when the villi, the microscopic, finger-like tentacles that line the wall of the small intestine erode away, leaving a virtually flat surface. This can result in the prevention of the absorption of nutrients and reduce digestive capabilities. If left untreated, this condition can result in dehydration, malnutrition, and a weakened ability to fight off illness.
With the 2013 FDA announcement that the drug would require and update on these risks, there came a small flood of Benicar lawsuits that is growing into a big one. Daiichi Sankyo, manufacture of Benicar, Benicar HCT, Azor and Tribenzor, has been accused by users of failing to adequately warn consumers and the medical community about the risk of sprue-like enteropathy condition associated with the use of Benicar.
Most Benicar lawsuits against Daiichi Sankyo are currently being filed in state court, though there a few spread throughout U.S. District Courts nationwide. Though not enough federal cases have been filed to warrant consolidated MDL proceedings that would make the claims a class action for discovery purposes. But the number of cases is growing and a class action may be inevitable. But for now, Daiichi Sankyo may have to face several different trial schedules. According to a case management order just issued in September, it appears the first trial date may be sometime in early 2016. The suit, filed by a woman who suffered chronic diarrhea and other side effects from Benicar HCT, began in California but was removed to the federal court system earlier this year. Discovery has been ordered to be completed by February 2015, with a pretrial set for December 18, 2015.
How Can Filing a Benicar Lawsuit Help Me?
There are no guarantees in litigation. But you may be entitled to money damages for the harm you have suffered. This would include medical bills, lost wages, and the biggest loss of all: physical, mental, and emotional suffering. Lawsuits do something else, too. The hold Daiichi Sankyo responsible for what has happened.
Can I File a Benicar Lawsuit?
Though in the very early stages of this litigation, if you have suffered negative side-effects as a result of taking a Benicar product, it is best to speak to an attorney that can help you as soon as possible. These cases can take a long time to investigate, so you should not wait given that many states have harsh statutes of limitation. Call to speak with an experienced attorney now, one who can give you a better understanding of the facts and where to go from here. We are waiting to hear from you at 1.800.553.8082, on online here.